Jennifer C. King, PhD leads scientific and research priorities for GO2 Foundation for Lung Cancer. She is a cancer research scientist turned patient advocate who uses her training to lead cutting-edge research initiatives to improve the lives of those living with or at risk for lung cancer. The GO2 Foundation Science and Research program includes a research portfolio of internal studies, collaborative partnerships, and external research funding, along with a personalized medicine program for patients and the patient-driven Lung Cancer Registry. Dr. King holds a Ph.D. in biology from the Massachusetts Institute of Technology and a B.S. from Duke University.

Andrew is Senior Manager of Clinical Research for GO2 Foundation for Lung Cancer. Originally a translational cancer researcher, Andrew transitioned to patient-advocacy to have increased impact on driving patient-centered research. At GO2 Foundation, Andrew leads implementation of research studies within the foundation’s Care Continuum Centers of Excellence, a network of community and academic clinical centers focused on lung cancer early detection and treatment. He also acts as a navigator for a treatment and clinical trial navigation program, called LungMATCH, directly working with lung cancer patients and their caregivers to help them understand and access appropriate care options.